Looks like you’re on the UK site. Choose another location to see content specific to your location

Fresenius invests in dialysis centres and renal hospitals in China

13th December 2018

Fresenius Medical Care is expanding its presence in China with acquisitions and investments in dialysis centres and renal hospitals. The company acquired a 70% share of Guangzhou KangNiDaiSi Medical Investment Co., Ltd, which focuses on dialysis and related chronic disease services, a 55% share of Henan Aishen Hospital Management Co. Ltd and Aishen Beijing Hospital Management, who are building 13 dialysis centres and a grade I renal hospital, and a 60% share of Daqing Kangda Dialysis Center Co., Ltd in Heilongjiang province.
These acquisitions have been announced at the same time as the announcement of a weak profits outlook for 2019, and the likelihood that 2020 profit targets will not be reached. Shares dropped 17.71% on this news.

We currently have 14 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.